The aetiology and natural history of Type I (insulindependent) diabetes mellitus are still not known but both genetics and environmental factors contribute to the development of the disease [1±3]. Although HLA genetics have a major role in the aetiology of Type I diabetes, other genes also contribute to the genetic effect, but the mode of inheritance of the disease is not clear [4] . The genetic effect contributes 70±75 % of the susceptibility to Type I diabetes [5, 6] . Environmental factors possibly initiate or trigger the process which leads to the destruction of the beta cells and the onset of diabetes [3, 7, 8] .
abetes Epidemiology Research International Group (DERI) started the collection of the aggregate data on incidence of Type I diabetes in the late 1970 s and the early 1980 s [10] . The efforts of the DERI group led to an increase in the number of registries on diabetic children and to the establishment of the World Health Organization Project of Childhood Diabetes (DIAbetes MONdiale) in 1990 [11] . The collaborative research project EURODIAB ACE was established also in the late 1980 s [12] to gather information of Type I diabetes in Europe. The latest reviews on the incidence of Type I diabetes among populations have indicated that differences in the incidence are 60-fold between the highest and the lowest rates [10, 12±14] . The highest incidence is found in Caucasoid populations, particularly in northern Europe, and the lowest rates are found in Asia and South America [13, 14] .
Thus far only one trend analysis of the incidence of Type I diabetes comparing simultaneously several but yet a limited number of populations has been carried out by the DERI group [15] . The standardized procedures agreed upon for the incidence data collected around the world now permit a comparative assessment of temporal trends among several populations. We estimated the temporal trends in the incidence of Type I diabetes from incidence data collected through a systematic literature review. A statistical analysis of the data was done in order to find out whether the incidence is increasing globally. Another objective was to evaluate quantitatively the extent to which the change in incidence of Type I diabetes differs among populations.
Materials and methods
Literature search. The literature was searched using MED-LINE, direct examination of reference lists of the articles, hand searches of selected journals and published conference abstracts. By the closing date, 28th February 1999, more than 160 original publications reporting time series of the incidence of Type I diabetes were found.
Inclusion criteria. The publications were further evaluated with the strict inclusion criteria in order to choose appropriate studies for the quantitative analysis. The inclusion criteria were: 1) the study period was 8 years or more, 2) the incidence rates were presented for each year separately, 3) the number of cases per year was five or more, 4) in the papers in which the age standardization had been reported, the incidences had been estimated with age standardization according to the world population and, 5) Type I diabetes was diagnosed according to the WHO definition. Studies comparing incidence rates estimated with different methods during different periods were excluded. No requirement for a minimum case-ascertainment level of the data source was made as reliable case ascertainment estimation had usually not been done until the 1990 s. The articles were evaluated by two independent reviewers according to the above-mentioned inclusion criteria.
Description of the data. Incidence data were obtained either from the tables or from the figures in the published articles. In approximately half of the original articles the annual incidence rates were presented in the tables and in another half in the figures only. The numbers derived from the figures were reconfirmed by the second reviewer. For Montreal (Canada), Allegheny County (USA), Scotland, Auckland (New Zealand), Prince Edward Island (Canada), Leicestershire (UK) and Wielkopolska (Poland) we used the original database of the DERI Study [15] .
Altogether 37 studies from 27 countries met the inclusion criteria and were included in the analysis (Table 1) . The registration of diabetic children was prospective in most of the studies. In 30 studies the age of children ranged from 0 to 14 years and in 7 studies from 0 to 15, 16, 17 and 19 years. The time period of the studies ranged from 8 to 32 years. The average length of the study period was 14.9 years (median 14 years). The estimates of the degree of case-ascertainment were high, ranging from 85 to 100 %. The degree of ascertainment remained unspecified only in five studies. The studies included in the analysis were from the period 1960 to 1996.
Statistical methods. The incidence of Type I diabetes for our analysis was taken from the individual studies as it was reported in these publications. The incidence for the data obtained from the DERI Study [15] was calculated per 100 000 people a year. Age standardization of the rates was done using 5-year intervals with the proportions 33/100, 33/100 and 34/100 (for the age groups 0±4 years, 5±9 years, and 10±14 years respectively) as the standard according to the approach by the DERI Study Group [16] , which is the same as the world population standard.
The temporal trend for each population was fitted by a simple linear regression under the assumption of normally distributed errors, with the age-standardized incidence as dependent variable expressed on a logarithmic scale and the calendar year as independent variable: lnl i (t) = a i + b i t, where l i (t) denote the age-standardized incidence predicted at year t for population i; the intercept a i is different for each population, and b i is the population specific regression coefficient (the trend), respectively. In such a multiplicative model the regression coefficient (´100 %) is a percentage, approximately being the average relative increase in incidence per year. The multiplicative regression model was used because it fitted the data well. It is commonly used in estimating time trends in incidence and allows a simple interpretation of the regression coefficient.
The overall estimate of the relative annual increase was obtained by using a pooled, centralized data set: to start, for each population the logarithms of the age-standardized incidence rates and the time points were centralized to make the different lengths of the studies and incidence levels more comparable. Then, using the method of least squares, a straight line constrained to cross the origin of the centralized coordinate system was fitted to the pooled data set. The regression coefficient has the same interpretation as in the population-wise analysis. The analysis was subsequently repeated as weighted regression, where the residual sum of squares was weighted with the number of cases in individual studies, to give more weight for observations with a higher number of cases.
The association between the level of incidence and increase in incidence was assessed by calculating the correlation coefficient between the logarithms of incidences in 1983 predicted by the model and the incidence increases estimated by the multiplicative model. The year 1983 was chosen because almost all studies covered it.
Predictions until the year 2010 have been made with both multiplicative and additive regression models, meaning that the curve produced by fitting the model to the data is simply extrapolated to the year 2010. In essence, the multiplicative model fits an exponential curve to the incidence, whereas the additive model fits a straight line. The additive regression model is used here to point out the differences between predictions when using alternative models.
Results
Incidence. The mean incidence of Type I diabetes among the study populations varied from 0.5 to 30.3 per 100 000 a year during the observation period (Table 1). The mean incidences were divided into quartiles: low incidence, less than 6.4 per 100 000 a year (the lowest 25 % of the mean incidences), intermediate 6.4±14.6 per 100 000 a year (50 % of the mean incidences, thus the two intermediate groups combined), and high, more than 14.6 per 100 000 a year (highest 25 % of the mean incidences).
Increase in the incidence of Type I diabetes. The relative change (% per year) in incidence among individual populations ranged from ±0.2 % in Colorado (USA) to 9.5 % in Leicestershire (UK) ( Table 2) . A statistically significant increase in incidence was found in 65 % (24/37) of the populations. An upward tendency in incidence not reaching statistical significance was observed in another 12 populations. Only in one population, Colorado (USA), the trend was slightly, but not significantly, negative (±0.2 % per year) and the upper limit of the 95 % confidence interval show that an increase of 2.2 % per year was possible.
The global trend and the annual increase in the incidence of Type I diabetes were estimated from the age-standardized incidence rates using the log-linear regression ( Table 2 ). The p value of less than 0.05 for the two-sided test for a non-zero regression coefficient was regarded as evidence for the trend. The global annual increase was 3.0 % (95 % CI 2.59; 3.33, p = 0.0001) during 1960 to 1996, showing a highly significant increasing trend. When the annual incidence rates were weighted with the number of cases in each individual study, the increase in incidence was 2.5 % (95 % CI 2.32; 2.66; p = 0.0001). The estimated population-wise regression lines illustrate well the increasing trends (Fig. 1, 2) .
Comparison of increase rates. The relation between the increase in incidence of Type I diabetes and the average level of incidence expressed as the incidence in 1983 estimated from the regression model is shown in Figure 3 . There was a significant inverse association between the increase and the logarithm of the level of incidence (r = ±0.56, p = 0.0004). The association indicates that the relative increase was more pronounced in the populations with a low incidence. Nevertheless, in the five populations with the highest incidence the increase was also statistically significant, varying from 1.2 to 3.2 % per year. The incidence level of Type I diabetes and its increase seemed to be similar in some geographically adjacent populations. For example in the northern European countries; Finland, Sweden and Norway where the incidence of Type I diabetes has been high for a long time, the increase was 1 to 3 % per year. Adjacent countries around the Baltic Sea, Estonia, Latvia, Lithuania and Poland with an intermediate or low incidence (4±10 per 100 000 a year) showed an upward course but not a statistically significant trend in incidence. The increase in incidence in eastern Europe varied from 2.1 % per year in East Bulgaria to 8.5 % per year in Hungary. In the United Kingdom the mean incidence ranged from 14.3 to 21.6 and the increase in incidence ranged between 1.9 and 3.7 % except for Leicestershire where the mean incidence was 7.8 with an increase of 9.5 %. The data for Leicestershire, however, were considerably older (from 1965 to 1981) than from other UK study populations.
Predictions until the year 2010. Since no effective prevention has thus far been invented or is foreseen in the near future, we used the observed trends to predict the incidence of Type I diabetes at least until the year 2010 (Table 3 ). For the prediction we applied both linear and exponential models, since the model of the increase in incidence is not known. The exponential predictions were only calculated for populations with a study period of at least 14 years. In general, the linear model produces more conservative predictions than the exponential model, however, in those populations where an increase had started during the very last years of the observation period, the exponential model gave more conservative predictions than the linear. The predictions based on the linear model show that Finland will still have the highest incidence in the world (50 per 100 000 a year) in the year 2010, followed by Norway, Prince Edward Island (Canada), western Australia, Scotland (UK), Oxford (UK), and Sweden. Despite the large relative increases in the incidence observed in China and Peru, the absolute incidence rates in these countries would still remain low, less than 2 per 100 000 a year. Based on these predictions, in Japan the incidence will be lower than 5 per 100 000 a year and in Poland, Latvia and Lithuania the incidence will be under 10 per 100 000 a year.
Discussion
There are also other populations in which an increase in the incidence of Type I diabetes has been recently reported such as Croatia, Denmark, Kuwait, the Netherlands, Russia and Switzerland [17±23]. These studies, however, did not meet the inclusion criteria of this study and were not included in our analysis. To find out whether the rising incidence is really a global phenomenon, we carried out an analysis of incidence trends among 37 populations worldwide for which the data had been collected for 8 years or more. The incidence of Type I diabetes is globally increasing by 3.0 % per year (or by 2.5 %, when the incidences were weighted by the number of diabetic children included in the individual studies). Confidence intervals for these estimates were fairly narrow indicating that these estimates are reliable. According to this estimate, the incidence of Type I diabetes will be 40 % higher in 2010 than in 1998. This is a realistic, although a rather frightening, scenario. . The model fitted to the incidence data was a multiplicative regression model with logarithm of the age standardized incidence as dependent variable, thus the scale of the incidence is logarithmic when straight lines were used in drawing the regression lines The global variation in the incidence of Type I diabetes is prominent [10, 13, 14] . It reflects the distribution of ethnic diversity showing the importance of the differential genetic susceptibility among populations. The incidence is higher among Caucasoid populations than among Mongoloids and Blacks. Within ethnic groups, however, there are geographical differences in incidence depending on the admixture between racial groups and possible environmental exposures [13] . Although most of the populations included in this analysis were Caucasoid, statistically significant increases in incidence were also found among the Asian populations in China and Japan, Mestizos in Peru and also among the Polynesians in Hawaii. In this literature review it was not possible to account for ethnic differences within populations because the authors of the original papers had usually not given detailed information on incidence in different ethnic groups. Where the ethnic groups had been analyzed separately, however, an increase in the incidence had been observed in all groups, but the rate of increase could vary from one ethnic group to another. Overall, the increase in the incidence of Type I diabetes does not seem to be restricted to any particular ethnic group.
In most countries with a low incidence the standardized incidence data have been collected during a relatively short period, which may in some cases explain the large relative change in incidence. The incidence of Type I diabetes possibly has been underestimated in earlier studies because of incomplete caseascertainment and death from undiagnosed diabetes. Among those populations where the study period was 18 years or more the increase in incidence was usually low (from 1.5 to 3.2 % per year except Japan, Hokkaido, 5.9 %). Therefore, results from several individual populations showing large increases should be interpreted cautiously when the number of cases Fig. 3 . Association between the increase in incidence and the level of incidence of Type I diabetes. The correlation coefficient between the log-transformed level of incidence predicted for 1983 and the increase in incidence was ±0.56 (p = 0.0004) for all populations. The increase in incidence was estimated from multiplicative regression models. For each population the level of incidence was calculated as the model-predicted There is presently no way to know whether the observed trend in incidence might reflect a change in the age at onset of diabetes instead of a true rise in prevalence. The increase in incidence in 0±14-yearolds might just be a transition of the age at onset from the age group 15 years or older. Data on incidence trends in older age groups exist from just a few populations; thus, reliable information a possible decrease in incidence in young adults is not available. Our main result is that the incidence is globally increasing in the age group of 0±14-year-olds.
The genetic factors have been shown to be important in the susceptibility to Type I diabetes [5, 6] . Although it is possible that the part of the population genetically predisposed for Type I diabetes is increasing, this increase may have been modest during the last decades and not alone a sufficient cause for the observed increase in incidence. The changes in the genetic code of the human populations are usually slow. In this analysis even the longest study period covered only 30 years, which is approximately the time span of one generation. It is very unlikely that a three to tenfold increase in the proportion of subjects with genetic susceptibility to Type I diabetes has taken place in any population during such a short time. Instead, the penetrance of the susceptibility genes might be changing. The penetrance is likely to be determined by an interaction between several susceptibility genes and unknown environmental factors [4, 24] .
During the recent years much attention has been paid to the identification and possible control of environmental factors which possibly initiate or trigger the process leading to Type I diabetes. Although some studies suggest associations between environmental factors such as diet and viral infections with the risk of Type I diabetes [25±35], their causative role has not been shown. It is also difficult to show that any of these environmental factors has changed in such a way that a continuous global increase in the incidence of Type I diabetes would be easily explained.
The incidence of Type I diabetes is increasing worldwide. Thus far no population has been identified in which the incidence has significantly decreased. The population-based WHO DIAMOND Project and the EURODIAB study started at the beginning of the 1990 s but have not yet reported results from the long-term progress in the incidence of Type I diabetes. It seems obvious that in both of these studies the 10-year monitoring period planned thus far is too short to produce reliable trend estimations and predictions for the change of the incidence of Type I diabetes, especially in countries where incidence is low. There is a need to continue with the community-based registries on Type I diabetes worldwide. Efforts are also needed to identify effective primary prevention measures for Type I diabetes to stop the global increase in the incidence of this disease.
